| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.85 | 0.0005 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.57 | 0.01 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.51 | 0.006 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.33 | 0.09 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.31 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.27 | 0.2 |